NCT04027296Completed
Development and Validation of the GLORI-COPD Score
Screening of COPD Patients at Risk of Complications in General Practice:
Source: ClinicalTrials.gov · Last updated 29 Apr 2026
Brief summary (registry, in English)
The objective of this study is to evaluate the diagnostic accuracy of the GLORI-COPD score in ambulatory care, to enable the screening of COPD patients at risk of complications, requiring early management
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 462 (actual)
- First submitted
- 18 Jul 2019
- Start date
- 1 May 2022
- Primary completion date
- 1 Nov 2025
- Lead sponsor
- University of Paris 5 - Rene Descartes
- Diseases
- COPD
- NCT number
- NCT04027296
What you commit to
- Study type: Observational
- Participants enrolled: 462
- From 1 May 2022 to the primary completion date, 1 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who have already been diagnosed with COPD by spirometry,
- have a contraindication to spirometry,
- have an estimated life expectancy of less than 5 years
- are under protective measures
Who the study is looking for
- age ≥ 35 yo
- smoker or former smoker ≥ 10 Pack Years
Age in the registry: 35 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Université Paris Cité Coordinator of this site? Confirm its status | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.